Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Radioactivity in Bottled Drinking Water from Greater Dhaka City and Concomitant Ingestion Doses to Consumers.

Health physics·2026

Same author

Corrigendum to "Exploring the therapeutic potential of copper nanoparticles for cancer treatment: a review" [Int. Immunopharmacol. 178 (2026) 116519].

International immunopharmacology·2026

Same author

Assessment of water quality of the Halda River using multiple WQI approaches: Implications for Riverine Ecosystem and Sustainable Management.

PloS one·2026

Same author

Green Nanomedicine from Eupatorium: Phytochemical-Driven Synthesis of Therapeutic Nanoparticles for Biomedical Applications.

Applied biochemistry and biotechnology·2026

Same author

Si-doped CsSrI<sub>3</sub> perovskites as potential dielectrics in MIM capacitors: recent advances, limitations and prospects.

RSC advances·2026

Same author

First-principles study of rare-earth-free Cs<sub>4</sub>SrI<sub>6</sub>:Tl, a zero-dimensional halide perovskite for scintillation applications.

RSC advances·2026

Search research articles

Related Experiment Video

Updated: Jul 18, 2025

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

Cyclodextrin nanoparticles in targeted cancer theranostics.

Roshnee Bose¹, Maharsh Jayawant¹, Rajesh Raut²

¹Amity Institute of Biotechnology, Amity University Maharashtra, Mumbai, Maharashtra, India.

Frontiers in Pharmacology

|August 21, 2023

Summary

Cyclodextrin (CD)-based nanoparticles are advancing cancer nanotheranostics. These adaptable nanocarriers show great potential for targeted drug delivery and improved cancer treatment outcomes.

Keywords:

cancer cyclodextrin diagnosis imaging theranostics

More Related Videos

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

Related Experiment Videos

Last Updated: Jul 18, 2025

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

Area of Science:

Nanotechnology
Oncology
Materials Science

Background:

Cancer nanotheranostics is a rapidly advancing field.
Cyclodextrins (CDs) are emerging as key nanocarriers in nanotheranostics.
CD-based nanoparticles offer adaptability and potential for targeted cancer therapy.

Purpose of the Study:

To review techniques for nanotheranostics applications of CD-associated complex compounds in cancer treatment.
To highlight the potential of CD-based nanoparticles in combating various cancers.
To explore innovative nanocomplex creation and drug delivery systems.

Main Methods:

Review of existing literature on cyclodextrin-based nanotheranostics.
Analysis of encapsulation and nanocomplex formation techniques.
Evaluation of in vivo experimental results for CD-drug conjugates.

Main Results:

Cyclodextrin-based nanoparticles demonstrate significant potential as nanocarriers for anti-cancer drugs.
Encapsulation and nanocomplexation techniques enable effective theranostic treatments.
In vivo studies show promising therapeutic outcomes for various cancers using CD-drug conjugates.

Conclusions:

Cyclodextrin nanotheranostics offer a promising approach for targeted drug delivery in cancer treatment.
Efficient nanocomplex development and drug delivery systems are crucial for therapeutic success.
Continued research in nanotheranostics holds potential for revolutionizing cancer care.